Ireland

--:--IST

Latest

Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide

Subscribe

Registers› Irish medicines ›Eisai GmbH

Medicines register · Ireland

Eisai GmbH — licensed medicines

15 medicines held by Eisai GmbH on the Irish market, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,295 authorised products are in this register. Synced 05 Oct 2026, 03:28 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Fycompa 0.5 mg film-coated tablets EU/1/12/776/024

Perampanel

—

Fycompa 10 mg film-coated tablets EU/1/12/776/011-013

Perampanel

—

Fycompa 12 mg film-coated tablets EU/1/12/776/014-016

Perampanel

—

Fycompa 2 mg film-coated tablets EU/1/12/776/001

Perampanel

—

Fycompa 4 mg film-coated tablets EU/1/12/776/002-004

Perampanel

—

Fycompa 6 mg film-coated tablets EU/1/12/776/005-007

Perampanel

—

Fycompa 8 mg film-coated tablets EU/1/12/776/008-010

Perampanel

—

HALAVEN 0.44 mg/ml solution for injection EU/1/11/678/001-002

Eribulin mesylate

—

Inovelon EU/1/06/378/1-16

Rufinamide

—

Inovelon 40 mg/ml oral suspension EU/1/06/378/017

Rufinamide

—

Kisplyx 10 mg hard capsules EU/1/16/1128/002

Lenvatinib mesilate

—

Kisplyx 4 mg hard capsules EU/1/16/1128/001

Lenvatinib mesilate

—

LENVIMA 10 mg hard capsules EU/1/15/1002/002

Lenvatinib mesylate

—

LENVIMA 4 mg hard capsules EU/1/15/1002/001

Lenvatinib mesylate

—

LEQEMBI 100 mg/mL concentrate for solution for infusion EU/1/24/1891/001-002

Lecanemab

—

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 6 October 2026. https://priyalifescience.com/medicines/company/eisai-gmbh

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.